RecruitingPhase 3NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Sponsor: Syndax Pharmaceuticals
Shreveport, LA · +5 more sites
2 recruiting leukemia studies with a site in Shreveport, LA.
Sponsor: Syndax Pharmaceuticals
Shreveport, LA · +5 more sites
Sponsor: AbbVie
Shreveport, LA · +31 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.